REDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AFTER SWITCH FROM DUAL THERAPY TO SINGLE-INHALER TRIPLE THERAPY IN A REAL-WORLD HEALTH CARE SETTING IN THE US

被引：0
|
作者：
McCormack, Meredith C.
Noorduyn, Stephen G.
Gronroos, Noelle
Lee, Lydia
Johnson, Mary
Wrobleski, Kristin
Veeranki, Phani
Ismaila, Afisi S.
Igboekwe, Emmeline
Paczkowski, Rosirene
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3204
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4942A / 4943A
页数：2
相关论文
共 50 条
  • [41] Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting
    Halpin, David M. G.
    Rothnie, Kieran J.
    Banks, Victoria
    Czira, Alexandrosz
    Compton, Chris
    Wood, Robert
    Tritton, Theo
    Massey, Olivia
    Wild, Rosie
    Snowise, Neil
    Nikitin, Kirill
    Sharma, Raj
    Ismaila, Afisi S.
    Vogelmeier, Claus F.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2417 - 2429
  • [42] Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan
    Oga, Toru
    Mita, Chifuku
    Ito, Risako
    Requena, Gema
    Rothnie, Kieran J.
    Noorduyn, Stephen G.
    Yuanita, Liza
    Yarita, Masao
    RESPIRATORY INVESTIGATION, 2024, 62 (04) : 685 - 694
  • [43] Cost-effectiveness of single-inhaler triple therapy for chronic obstructive pulmonary disease treatment by baseline blood eosinophil count: IMPACT trial
    Shah, Dhvani
    Martin, Alan
    Kendall, Robyn
    Risebrough, Nancy
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [44] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After 1 Year: TriMaximize-A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Voves, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Nevels, R.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S541 - S541
  • [45] Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Improves Lung Function and Symptoms Compared with Tiotropium Monotherapy in Patients with Symptomatic Chronic Obstructive Pulmonary Disease at Risk of Exacerbations
    Obeid, D.
    Bansal, S.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Erb, D.
    Harvey, C.
    Kaisermann, M. C.
    Kaye, M.
    Lipson, D. A.
    Martin, N.
    Zhu, C. Q.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [46] Analysis of Chronic Obstructive Pulmonary Disease Exacerbations With the Triple Therapy Compared With Dual and Single Bronchodilator Therapy: Which Treatment Is Better for Patients With Severe Disease?
    Sadigov, Alizamin
    Akhundov, Sakhavatdin
    Bagirov, Rovshan
    CHEST, 2014, 145 (03)
  • [47] Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety
    Suissa, Samy
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (03)
  • [48] Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease
    Singh, Dave
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1279 - 1287
  • [49] Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study
    Rothnie, Kieran J.
    Wood, Robert P.
    Czira, Alexandrosz
    Banks, Victoria L.
    Camidge, Lucinda J.
    Massey, Olivia K., I
    Seif, Monica
    Compton, Chris
    Sharma, Raj
    Halpin, David M. G.
    Ismaila, Afisi S.
    Vogelmeier, Claus F.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [50] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
12345